A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

NCT02704429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Pemphigus Vulgaris

Interventions

DRUG: PRN1008

Sponsor

Principia Biopharma, a Sanofi Company